Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.

Theresa HiltnerMeike KohlrussAnna-Lina HerzSylvie LorenzenAlexander NovotnyAlexander HapfelmeierMoritz JesinghausJulia Slotta-HuspeninaLeila SisicMatthias M GaidaWilko WeichertKatja OttGisela Keller

Published in: Journal of cancer research and clinical oncology (2023)

OS in gastric/gastroesophageal cancer after CTx might depend on sex and MSI status and may differ between patients treated with or without a taxane compound in the chemotherapeutic regimen.

Keyphrases

neoadjuvant chemotherapy
end stage renal disease
newly diagnosed
ejection fraction
locally advanced
chronic kidney disease
lymph node
sentinel lymph node
prognostic factors
early stage
papillary thyroid
peritoneal dialysis
metastatic breast cancer
radiation therapy
rectal cancer
patient reported